Annual CFO
-$713.97 M
-$298.03 M-71.65%
December 31, 2023
Summary
- As of February 7, 2025, NVAX annual cash flow from operations is -$713.97 million, with the most recent change of -$298.03 million (-71.65%) on December 31, 2023.
- During the last 3 years, NVAX annual CFO has fallen by -$671.43 million (-1578.30%).
- NVAX annual CFO is now -321.08% below its all-time high of $322.95 million, reached on December 31, 2021.
Performance
NVAX Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$144.81 M
-$459.08 M-146.08%
September 30, 2024
Summary
- As of February 7, 2025, NVAX quarterly cash flow from operations is -$144.81 million, with the most recent change of -$459.08 million (-146.08%) on September 30, 2024.
- Over the past year, NVAX quarterly CFO has dropped by -$105.16 million (-265.18%).
- NVAX quarterly CFO is now -121.84% below its all-time high of $663.09 million, reached on March 31, 2021.
Performance
NVAX Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$90.88 M
-$105.16 M-736.51%
September 30, 2024
Summary
- As of February 7, 2025, NVAX TTM cash flow from operations is -$90.88 million, with the most recent change of -$105.16 million (-736.51%) on September 30, 2024.
- Over the past year, NVAX TTM CFO has increased by +$564.12 million (+86.13%).
- NVAX TTM CFO is now -113.52% below its all-time high of $672.43 million, reached on June 30, 2021.
Performance
NVAX TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
NVAX Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -71.7% | -265.2% | +86.1% |
| 3 y3 years | -1578.3% | +57.7% | -128.1% |
| 5 y5 years | -286.3% | -526.6% | +16.7% |
NVAX Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -321.1% | at low | -146.1% | +57.7% | -128.1% | +87.8% |
| 5 y | 5-year | -321.1% | at low | -121.8% | +57.7% | -113.5% | +87.8% |
| alltime | all time | -321.1% | at low | -121.8% | +57.7% | -113.5% | +87.8% |
Novavax Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$144.81 M(-146.1%) | -$90.88 M(-736.5%) |
| Jun 2024 | - | $314.27 M(-476.1%) | $14.28 M(-103.0%) |
| Mar 2024 | - | -$83.56 M(-52.7%) | -$471.93 M(-33.9%) |
| Dec 2023 | -$713.97 M(+71.7%) | -$176.78 M(+345.8%) | -$713.97 M(+9.0%) |
| Sep 2023 | - | -$39.66 M(-76.9%) | -$655.00 M(+0.1%) |
| Jun 2023 | - | -$171.94 M(-47.2%) | -$654.05 M(+0.2%) |
| Mar 2023 | - | -$325.59 M(+176.4%) | -$653.02 M(+57.0%) |
| Dec 2022 | -$415.94 M(-228.8%) | -$117.82 M(+204.4%) | -$415.94 M(-35.1%) |
| Sep 2022 | - | -$38.71 M(-77.4%) | -$640.53 M(-13.9%) |
| Jun 2022 | - | -$170.90 M(+93.1%) | -$743.96 M(+73.6%) |
| Mar 2022 | - | -$88.51 M(-74.2%) | -$428.65 M(-232.7%) |
| Dec 2021 | $322.95 M(-859.1%) | -$342.41 M(+140.9%) | $322.95 M(-39.8%) |
| Sep 2021 | - | -$142.14 M(-198.4%) | $536.79 M(-20.2%) |
| Jun 2021 | - | $144.41 M(-78.2%) | $672.43 M(+4.5%) |
| Mar 2021 | - | $663.09 M(-615.7%) | $643.65 M(-1613.0%) |
| Dec 2020 | -$42.54 M(-68.9%) | -$128.57 M(+1878.9%) | -$42.54 M(-168.3%) |
| Sep 2020 | - | -$6.50 M(-105.6%) | $62.28 M(+70.5%) |
| Jun 2020 | - | $115.63 M(-600.4%) | $36.52 M(-133.5%) |
| Mar 2020 | - | -$23.11 M(-2.7%) | -$109.13 M(-20.1%) |
| Dec 2019 | -$136.62 M(-26.1%) | -$23.74 M(-26.4%) | -$136.62 M(-13.6%) |
| Sep 2019 | - | -$32.26 M(+7.5%) | -$158.15 M(-0.8%) |
| Jun 2019 | - | -$30.01 M(-40.7%) | -$159.40 M(-5.9%) |
| Mar 2019 | - | -$50.61 M(+11.8%) | -$169.36 M(-8.4%) |
| Dec 2018 | -$184.82 M(+27.9%) | -$45.27 M(+35.1%) | -$184.82 M(+1.0%) |
| Sep 2018 | - | -$33.51 M(-16.2%) | -$182.96 M(-5.5%) |
| Jun 2018 | - | -$39.97 M(-39.5%) | -$193.62 M(+16.6%) |
| Mar 2018 | - | -$66.08 M(+52.3%) | -$166.05 M(+14.9%) |
| Dec 2017 | -$144.48 M(-44.2%) | -$43.40 M(-1.8%) | -$144.48 M(-12.8%) |
| Sep 2017 | - | -$44.18 M(+256.2%) | -$165.63 M(-9.9%) |
| Jun 2017 | - | -$12.40 M(-72.1%) | -$183.81 M(-21.3%) |
| Mar 2017 | - | -$44.50 M(-31.1%) | -$233.43 M(-9.8%) |
| Dec 2016 | -$258.77 M(+105.2%) | -$64.55 M(+3.5%) | -$258.77 M(+3.9%) |
| Sep 2016 | - | -$62.36 M(+0.5%) | -$248.97 M(+15.7%) |
| Jun 2016 | - | -$62.03 M(-11.2%) | -$215.14 M(+30.0%) |
| Mar 2016 | - | -$69.83 M(+27.5%) | -$165.43 M(+31.2%) |
| Dec 2015 | -$126.09 M(+88.2%) | -$54.75 M(+91.9%) | -$126.09 M(+38.4%) |
| Sep 2015 | - | -$28.53 M(+131.5%) | -$91.11 M(+16.1%) |
| Jun 2015 | - | -$12.32 M(-59.6%) | -$78.45 M(+1.8%) |
| Mar 2015 | - | -$30.49 M(+54.2%) | -$77.07 M(+15.0%) |
| Dec 2014 | -$67.01 M(+47.7%) | -$19.77 M(+24.5%) | -$67.01 M(+12.6%) |
| Sep 2014 | - | -$15.87 M(+45.1%) | -$59.51 M(+1.7%) |
| Jun 2014 | - | -$10.94 M(-46.4%) | -$58.52 M(+6.0%) |
| Mar 2014 | - | -$20.43 M(+66.6%) | -$55.21 M(+21.7%) |
| Dec 2013 | -$45.36 M(+148.8%) | -$12.26 M(-17.6%) | -$45.36 M(+24.8%) |
| Sep 2013 | - | -$14.88 M(+94.9%) | -$36.35 M(+39.3%) |
| Jun 2013 | - | -$7.63 M(-27.9%) | -$26.10 M(+6.1%) |
| Mar 2013 | - | -$10.58 M(+225.4%) | -$24.59 M(+34.9%) |
| Dec 2012 | -$18.23 M(-22.9%) | -$3.25 M(-29.8%) | -$18.23 M(+2.1%) |
| Sep 2012 | - | -$4.63 M(-24.4%) | -$17.85 M(+7.9%) |
| Jun 2012 | - | -$6.13 M(+45.2%) | -$16.54 M(-12.1%) |
| Mar 2012 | - | -$4.22 M(+47.1%) | -$18.81 M(-20.4%) |
| Dec 2011 | -$23.63 M(-28.1%) | -$2.87 M(-13.6%) | -$23.63 M(-11.1%) |
| Sep 2011 | - | -$3.32 M(-60.5%) | -$26.57 M(-15.8%) |
| Jun 2011 | - | -$8.40 M(-7.1%) | -$31.56 M(-2.9%) |
| Mar 2011 | - | -$9.04 M(+55.7%) | -$32.51 M(-1.0%) |
| Dec 2010 | -$32.85 M | -$5.81 M(-30.2%) | -$32.85 M(-16.7%) |
| Sep 2010 | - | -$8.32 M(-11.0%) | -$39.43 M(+5.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2010 | - | -$9.35 M(-0.4%) | -$37.53 M(+5.8%) |
| Mar 2010 | - | -$9.38 M(-24.3%) | -$35.48 M(+8.1%) |
| Dec 2009 | -$32.83 M(+35.0%) | -$12.39 M(+93.0%) | -$32.83 M(+20.9%) |
| Sep 2009 | - | -$6.42 M(-12.1%) | -$27.16 M(-12.8%) |
| Jun 2009 | - | -$7.30 M(+8.5%) | -$31.16 M(+20.6%) |
| Mar 2009 | - | -$6.73 M(+0.1%) | -$25.84 M(+6.3%) |
| Dec 2008 | -$24.31 M(-9.1%) | -$6.72 M(-35.5%) | -$24.31 M(+7.9%) |
| Sep 2008 | - | -$10.42 M(+428.8%) | -$22.52 M(+5.9%) |
| Jun 2008 | - | -$1.97 M(-62.1%) | -$21.27 M(-15.8%) |
| Mar 2008 | - | -$5.20 M(+5.4%) | -$25.25 M(-5.6%) |
| Dec 2007 | -$26.74 M(+80.6%) | -$4.93 M(-46.1%) | -$26.74 M(+10.4%) |
| Sep 2007 | - | -$9.16 M(+53.9%) | -$24.22 M(+32.3%) |
| Jun 2007 | - | -$5.95 M(-11.1%) | -$18.30 M(+6.5%) |
| Mar 2007 | - | -$6.70 M(+177.4%) | -$17.18 M(+16.0%) |
| Dec 2006 | -$14.81 M(+154.9%) | -$2.41 M(-25.5%) | -$14.81 M(+216.6%) |
| Sep 2006 | - | -$3.24 M(-32.9%) | -$4.68 M(+110.0%) |
| Jun 2006 | - | -$4.83 M(+11.6%) | -$2.23 M(+25.3%) |
| Mar 2006 | - | -$4.33 M(-156.1%) | -$1.78 M(-69.4%) |
| Dec 2005 | -$5.81 M(-80.7%) | $7.72 M(-1078.2%) | -$5.81 M(-74.7%) |
| Sep 2005 | - | -$789.00 K(-82.0%) | -$22.92 M(-28.6%) |
| Jun 2005 | - | -$4.38 M(-47.6%) | -$32.09 M(-4.4%) |
| Mar 2005 | - | -$8.36 M(-11.0%) | -$33.57 M(+11.5%) |
| Dec 2004 | -$30.10 M(+71.5%) | -$9.39 M(-5.7%) | -$30.10 M(+25.4%) |
| Sep 2004 | - | -$9.96 M(+70.2%) | -$24.01 M(+40.5%) |
| Jun 2004 | - | -$5.85 M(+19.7%) | -$17.08 M(-2.5%) |
| Mar 2004 | - | -$4.89 M(+48.1%) | -$17.52 M(-0.2%) |
| Dec 2003 | -$17.55 M(-16.7%) | -$3.30 M(+8.7%) | -$17.55 M(-5.5%) |
| Sep 2003 | - | -$3.04 M(-51.7%) | -$18.57 M(-13.3%) |
| Jun 2003 | - | -$6.28 M(+27.6%) | -$21.42 M(+16.0%) |
| Mar 2003 | - | -$4.92 M(+13.9%) | -$18.47 M(-12.3%) |
| Dec 2002 | -$21.07 M(+361.4%) | -$4.32 M(-26.6%) | -$21.07 M(+10.0%) |
| Sep 2002 | - | -$5.89 M(+76.7%) | -$19.16 M(+32.0%) |
| Jun 2002 | - | -$3.33 M(-55.7%) | -$14.51 M(+59.5%) |
| Mar 2002 | - | -$7.52 M(+211.2%) | -$9.10 M(+99.2%) |
| Dec 2001 | -$4.57 M(-54.5%) | -$2.42 M(+94.8%) | -$4.57 M(-16.9%) |
| Sep 2001 | - | -$1.24 M(-159.6%) | -$5.50 M(-21.9%) |
| Jun 2001 | - | $2.08 M(-169.6%) | -$7.03 M(-37.2%) |
| Mar 2001 | - | -$2.99 M(-10.6%) | -$11.20 M(+11.5%) |
| Dec 2000 | -$10.04 M(+171.5%) | -$3.35 M(+20.4%) | -$10.04 M(+43.5%) |
| Sep 2000 | - | -$2.78 M(+33.7%) | -$7.00 M(+29.1%) |
| Jun 2000 | - | -$2.08 M(+12.9%) | -$5.42 M(+9.7%) |
| Mar 2000 | - | -$1.84 M(+513.3%) | -$4.94 M(+33.5%) |
| Dec 1999 | -$3.70 M(+2.8%) | -$300.00 K(-75.0%) | -$3.70 M(-14.0%) |
| Sep 1999 | - | -$1.20 M(-25.0%) | -$4.30 M(+2.4%) |
| Jun 1999 | - | -$1.60 M(+166.7%) | -$4.20 M(+20.0%) |
| Mar 1999 | - | -$600.00 K(-33.3%) | -$3.50 M(-2.8%) |
| Dec 1998 | -$3.60 M(-14.3%) | -$900.00 K(-18.2%) | -$3.60 M(-5.3%) |
| Sep 1998 | - | -$1.10 M(+22.2%) | -$3.80 M(0.0%) |
| Jun 1998 | - | -$900.00 K(+28.6%) | -$3.80 M(0.0%) |
| Mar 1998 | - | -$700.00 K(-36.4%) | -$3.80 M(-9.5%) |
| Dec 1997 | -$4.20 M(+27.3%) | -$1.10 M(0.0%) | -$4.20 M(+5.0%) |
| Sep 1997 | - | -$1.10 M(+22.2%) | -$4.00 M(+8.1%) |
| Jun 1997 | - | -$900.00 K(-18.2%) | -$3.70 M(0.0%) |
| Mar 1997 | - | -$1.10 M(+22.2%) | -$3.70 M(+12.1%) |
| Dec 1996 | -$3.30 M | -$900.00 K(+12.5%) | -$3.30 M(+37.5%) |
| Sep 1996 | - | -$800.00 K(-11.1%) | -$2.40 M(+50.0%) |
| Jun 1996 | - | -$900.00 K(+28.6%) | -$1.60 M(+128.6%) |
| Mar 1996 | - | -$700.00 K | -$700.00 K |
FAQ
- What is Novavax annual cash flow from operations?
- What is the all time high annual CFO for Novavax?
- What is Novavax annual CFO year-on-year change?
- What is Novavax quarterly cash flow from operations?
- What is the all time high quarterly CFO for Novavax?
- What is Novavax quarterly CFO year-on-year change?
- What is Novavax TTM cash flow from operations?
- What is the all time high TTM CFO for Novavax?
- What is Novavax TTM CFO year-on-year change?
What is Novavax annual cash flow from operations?
The current annual CFO of NVAX is -$713.97 M
What is the all time high annual CFO for Novavax?
Novavax all-time high annual cash flow from operations is $322.95 M
What is Novavax annual CFO year-on-year change?
Over the past year, NVAX annual cash flow from operations has changed by -$298.03 M (-71.65%)
What is Novavax quarterly cash flow from operations?
The current quarterly CFO of NVAX is -$144.81 M
What is the all time high quarterly CFO for Novavax?
Novavax all-time high quarterly cash flow from operations is $663.09 M
What is Novavax quarterly CFO year-on-year change?
Over the past year, NVAX quarterly cash flow from operations has changed by -$105.16 M (-265.18%)
What is Novavax TTM cash flow from operations?
The current TTM CFO of NVAX is -$90.88 M
What is the all time high TTM CFO for Novavax?
Novavax all-time high TTM cash flow from operations is $672.43 M
What is Novavax TTM CFO year-on-year change?
Over the past year, NVAX TTM cash flow from operations has changed by +$564.12 M (+86.13%)